tructural variation is often regarded as a genetic abnormality with negative consequences. This is perhaps not surprising, since some of the best-documented instances of structural variation were detected through analysis of aberrant human cells 1,2 and tumors 3 . However, recent analyses show that structural variation is a normal aspect of natural genetic variation. For example, a recent analysis of 2504 human genome sequences finds that structural variation is common between human individuals and population groups 4 . While it is still unclear to what extent such structural variation helped shape human evolution, experiments with microbes clearly indicate that large-scale rearrangements are an important driver of genetic adaptation to new environments (reviewed in ref. 5 ).
complex recombination events in each mutant 10 . Importantly, recombination events were limited to loxPsym sites, with the rest of the genome left untouched.
SCRaMbLE allows investigating how structural variation can lead to phenotypic changes. One way to do this will be to grow pools of variants in different stressful environments. Variants showing improved fitness can easily be enriched by prolonged exposure to the stress, and long-read whole-genome sequencing allows determining the structure of the recombined genomes. This enables researchers to study the phenotypic effect of genetic perturbations that are difficult to obtain using "traditional" genetic engineering strategies (inversions, duplications, translocations, etc.), and will thus further expand our knowledge of complex phenotypes.
However, there are still some pitfalls. Firstly, rearrangements are difficult to re-engineer one by one, making it difficult to distinguish the rearrangements that are associated with the change in fitness from other, neutral or slightly detrimental rearrangements. A second, and perhaps more important pitfall is that the rearrangements obtained through SCRaMbLE only occur between loxPsym sites and may therefore not be a perfect representation of naturally occurring events. Moreover, it is also still unclear if and how the rearrangements are influenced by the relative positioning of the loxPsym sites. Thirdly, deleting or amplifying certain genes can be lethal, causing recombination biases that can stretch over several kilobases. Lastly, SCRaMbLE is limited to strains harbouring the loxPsym sites, which is currently only the S288c lab strain.
Non-essential native gene 
example, while the production of artemisinic acid in yeast is arguably the greatest achievement in fungal synthetic biology thus far, it was estimated to have required roughly 100 postdoc years 11, 12 . Theoretically, engineering such complex pathways could be sped up drastically with clever design of loxPsym-containing neochromosomes, or recombination-mediated integration of LoxPsym-flanked DNA containing required genes. Since gene expression depends on the chromosomal location 13 , this approach can be applied for combinatorial optimization of pathway gene expression levels. Moreover, since the loxP-mediated recombination system is not specific for S. cerevisiae, the general concept of SCRaMbLE can be extrapolated to other industrially relevant yeasts and bacteria 14, 15 . As the cost of synthetic DNA keeps falling, and the availability of CRISPR-Cas9-based strategies for rapid and efficient integration of heterologous DNA, it seems likely that other industrially relevant organisms will be equipped with recombination sites to perform SCRaMbLE.
Taken together, it is clear that SCRaMbLE is a promising new way to obtain superior microbes for industrial applications. Large pools of genetic variants differing in gene content and genome structure can be obtained in just a matter of days and, thus, parallel optimization of complex multigenic traits can be performed. The technology complements the existing toolbox, from classic breeding, mutagenesis and genome shuffling over directed evolution to genetic engineering 16 . Importantly, the technology is orthogonal to these existing methods, as the type of changes that SCRaMbLE induces is fundamentally different. Hence, it seems interesting to combine SCRaMbLE with other techniques.
That said, there are also limitations. Firstly, the dependence on loxP or loxPsym sites implies that recombination is not completely random and that the recombination sites need to be carefully chosen. Moreover, as SCRaMbLE results in extremely large pools of genetically diverse mutants, its applicability for industrial strain development depends on whether the phenotype of interest is easily selectable for. Therefore, finding clever strategies to detect improved variants, even for "difficult" phenotypes like production of specific metabolites, is vital. Lastly, it is important to realize that structural variation is sometimes seen as a "quick and dirty" way to rapidly optimize a phenotype. Other mutation events, including smaller rearrangements and changes in the DNA sequence may be needed to further optimize the phenotype under selection without scarifying other desirable traits. Still, SCRaMbLE is clearly more than a gimmick, and it will be exciting to see how the technology will help us to develop novel drugs, biomaterials or chemicals, and reach higher productivity, quality and sustainability in various industries. 
